CLINICAL_TRIALS
trial_result
· 2015-02-12
Clinical Trial Update: A Safety Study of TTP4000 in Subjects With Alzheimer's Disease [Phase 1]
Summary
This document provides an update on a Phase 1 safety study of TTP4000 in Alzheimer's disease. The trial status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: vTv Therapeutics | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED